Classes
Publications
- The Anticancer Drug Ellipticine Induces Cytochromes P450 1A1, 1A2 and 3A, Cytochrome b(5) and NADPH:Cytochrome P450 Oxidoreductase in Rat Liver, Kidney and Lung2013 | Faculty of Science
- Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy2011 | Faculty of Science
- Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA2008 | Faculty of Science
- The impact of individual human cytochrome P450 enzymes on oxidative metabolism of anticancer drug lenvatinib2022 | Faculty of Science
- Nanomedicine of tyrosine kinase inhibitors2021 | Faculty of Science, Second Faculty of Medicine
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Faculty of Science, Second Faculty of Medicine
- Effect of the natural flavonoids myricetin and dihydromyricetin on the wound healing process in vitro2021 | Faculty of Science
- Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats2021 | Faculty of Science
- Does Dihydromyricetin Impact on Alcohol Metabolism2020 | Faculty of Science, First Faculty of Medicine
- In vivo metabolism of aristolochic acid I and II in rats is influenced by their co-exposure2020 | Faculty of Science
Loading network view...